Literature DB >> 11448380

Clinical significance of esophageal histologic findings after antireflux surgery.

T K Rantanen1, J T Salminen, J E Mäkinen, P I Sipponen, T A Kiviluoto, J A Salo.   

Abstract

HYPOTHESIS: Only limited and controversial information exists regarding the histologic effect of successful antireflux surgery on esophageal mucosa and its clinical significance. DESIGN AND SETTINGS: A randomized, blinded follow-up study conducted in a university hospital between January 1, 1992, and December 31, 1997, with a mean follow-up of 8 months. PATIENTS: Forty patients with severe symptomatic gastroesophageal reflux disease (24 men and 16 women; mean age, 50 years). MAIN OUTCOME MEASURES: Microscopic signs and severity of esophagitis analyzed by 2 blinded histopathologists.
RESULTS: Histopathologist 1 interpreted 22 (69%) of 32 postoperative biopsy specimens as normal; 7 (22%), as showing mild changes; 1 (3%), moderate changes; and 2 (6%), severe changes of reflux esophagitis. Histopathologist 2 interpreted 25 (78%) of 32 postoperative biopsy specimens as normal (P =.001); 1 (3%), as showing mild changes (P =.003); 4 (13%), moderate changes; and 2 (6%), severe changes. Between histopathologist 1 (90.6%) and histopathologist 2 (81%), the absence of esophageal mucosal inflammation correlated best with normalized pH monitoring.
CONCLUSIONS: These findings suggest that, if other findings such as those from fundic wrap at endoscopy and 24-hour pH monitoring are normal, the clinical significance of routine esophageal histologic examination after successful fundoplication is limited.

Entities:  

Mesh:

Year:  2001        PMID: 11448380     DOI: 10.1001/archsurg.136.7.733

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  1 in total

1.  Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study.

Authors:  Tuuli Kauttu; Jari Räsänen; Leena Krogerus; Eero Sihvo; Pauli Puolakkainen; Jarmo A Salo
Journal:  Surg Endosc       Date:  2012-01-05       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.